SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-19-000782
Filing Date
2019-06-21
Accepted
2019-06-21 20:01:28
Documents
1
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 form4a-06212019_050614.html 4/A  
1 form4a-06212019_050614.xml 4/A 3891
  Complete submission text file 0001415889-19-000782.txt   5377
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/OAZURRX BIOPHARMA,INC.760 PARKSIDE AVE DOWNSTATE BIOTECHNOLOGY INCUBATOR,STE217 BROOKLY NY 11226
Business Address
Riddell Alastair (Reporting) CIK: 0001681349 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37853 | Film No.: 19913033